Results 211 to 220 of about 241,744 (291)

Pharmacokinetics modulation in solid tumors through thrombin-embedded nanomedicine. [PDF]

open access: yesJ Nanobiotechnology
Lin S   +12 more
europepmc   +1 more source

Discovering new hub genes of dilated cardiomyopathy

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Dilated cardiomyopathy (DCM) has a poor prognosis and exhibits a complex and diverse aetiology and genetic profile. The genes responsible for the pathogenesis of DCM have not been fully identified. The present study aimed to explore new hub genes of DCM by mining the human DCM databases and further by experimental validation.
Jun‐Yan Zhu   +9 more
wiley   +1 more source

Photoaffinity labeling of a single receptor for alpha-thrombin on mouse embryo cells.

open access: hybrid, 1979
Darrel H. Carney   +5 more
openalex   +1 more source

Percutaneous mechanical circulatory support for acute right heart failure: A practical approach

open access: yesESC Heart Failure, EarlyView.
This is an overview of percutaneous mechanical circulatory support options for acute right heart failure, illustrating key clinical scenarios, device types, and principles of tailored device selection based on haemodynamics and underlying pathology. Abstract Acute right heart failure (RHF) represents a critical entity with significant morbidity and ...
Mario Gramegna   +18 more
wiley   +1 more source

Current and novel biomarkers in cardiogenic shock

open access: yesEuropean Journal of Heart Failure, EarlyView.
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy